Neuvasq develops therapeutics to restore neurovascular function, including NVQ042 for vascular retinopathies and NVQ061 to target neurodegenerative diseases like Alzheimer’s, Parkinson’s, multiple sclerosis, and epilepsy.
About
Join us
Become a BioWin member today and benefit from improved networking and industry intelligence in the life sciences and health sector.